Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.64B | $11.76B | $9.90B | $9.64B | $9.17B | $8.24B | $6.55B | $6.28B | $5.84B | $5.97B | $3.34B | $4.35B | $1.73B | $1.36B | $1.33B |
| Operating expenses | $5.00B | $4.97B | $4.29B | $3.65B | $3.70B | $3.00B | $2.53B | $2.40B | $2.26B | $2.34B | $1.59B | $1.64B | $808.0M | $536.0M | $534.0M |
| Operating income | $4.93B | $4.31B | $3.69B | $3.64B | $3.45B | $3.03B | $2.67B | $2.58B | $2.38B | $2.17B | $1.75B | $1.45B | $790.0M | $827.0M | $793.0M |
| EBITDAderived | $6.49B | $5.85B | $4.91B | $4.67B | $4.46B | $3.78B | $3.33B | $3.17B | $2.91B | $2.78B | $2.12B | $1.78B | $946.0M | $958.0M | $925.0M |
| Net income | $3.31B | $2.75B | $2.37B | $1.45B | $4.06B | $2.09B | $1.93B | $1.99B | $2.53B | $1.43B | $1.27B | $981.0M | $254.0M | $552.0M | $510.0M |
| Basic EPSper diluted share | $5.79 | $4.80 | $4.20 | $2.59 | $7.22 | $3.79 | $3.44 | $3.46 | $4.29 | $2.40 | $2.29 | $1.72 | $3.24 | $7.59 | $6.97 |
| Diluted EPSper diluted share | $5.77 | $4.78 | $4.19 | $2.58 | $7.18 | $3.77 | $3.42 | $3.43 | $4.25 | $2.39 | $2.28 | $1.71 | $3.21 | $7.52 | $6.90 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | Hague William JeffersonDirector | SellCommon Stock | 1.3K | $139.46 | $185.9K | 20.1K |
| Jun 9, 2026Form 4 · 10b5-1 | Hague William JeffersonDirector | SellCommon Stock | 91 | $138.50 | $12.6K | 21.5K |
| May 26, 2026Form 4 · 10b5-1 | Surdykowski Andrew JGeneral Counsel | SellCommon Stock | 2.6K | $152.00 | $396.4K | 45.5K |
| May 26, 2026Form 4 · 10b5-1 | Surdykowski Andrew JGeneral Counsel | SellCommon Stock | 2.0K | $150.97 | $296.7K | 48.1K |
| May 22, 2026Form 4 · 10b5-1 | Bowen SharonDirector | SellCommon Stock | 667 | $151.28 | $100.9K | 15.1K |